REQUEST A DEMO
Total
USD $0.00
Search more companies

Paypiersa Pharma S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Paypiersa Pharma S.A. Profile Updated: April 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Paypiersa Pharma S.A. is based in Ecuador. The head office is in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on August 04, 1998. 4 (2024) employees currently work for Paypiersa Pharma S.A.. In its most recent financial highlights, the company reported a net sales revenue increase of 18.17% in 2025. Over the same period, its total assets grew by 28.56%. The enterprise’s net profit margin increased by 0.72% in 2025.

Headquarters
Calle Luis Orrantia
Guayaquil; Guayas;

Contact Details: Purchase the Paypiersa Pharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Paypiersa Pharma S.A. report to view the information.
Registered Capital:
Purchase the Paypiersa Pharma S.A. report to view the information.
Financial Auditors:
Purchase the Paypiersa Pharma S.A. report to view the information.
Incorporation Date:
August 04, 1998
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
34%
Purchase this report to view the information.
34%
Purchase this report to view the information.
32%
Company Performance
Financial values in the chart are available after Paypiersa Pharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
18.17%
Total Operating Revenue
22.52%
Operating Profit
60.75%
EBITDA
23.33%
Net Profit/Loss for the Period
28.7%
Total Assets
28.56%
Total Equity
-19.89%
Operating Profit Margin
2.92%
Net Profit Margin
0.72%
Return on Equity (ROE)
20.71%
Debt / Equity
107.92%
Quick Ratio
-0.79%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?